Redhill Biopharma - 13 Year Stock Price History | RDHL

Historical daily share price chart and data for Redhill Biopharma since 2013 adjusted for splits and dividends. The latest closing stock price for Redhill Biopharma as of September 18, 2026 is 0.57.
  • The all-time high Redhill Biopharma stock closing price was 19790.00 on June 16, 2015.
  • The Redhill Biopharma 52-week high stock price is 2.79, which is 389.5% above the current share price.
  • The Redhill Biopharma 52-week low stock price is 0.54, which is 5.3% below the current share price.
  • The average Redhill Biopharma stock price for the last 52 weeks is 1.03.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Redhill Biopharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2026 0.8879 1.0300 1.4000 0.5500 0.5683 -44.83%
2025 2.3844 6.4000 6.6384 1.0200 1.0300 -83.41%
2024 11.5301 36.5000 37.5000 6.2100 6.2100 -82.99%
2023 72.8278 177.0000 259.0000 7.6625 36.5000 -73.98%
2022 1255.4606 2780.0000 3120.0000 137.8000 140.3000 -94.56%
2021 6494.1865 8170.0000 11290.0000 2310.0000 2580.0000 -68.07%
2020 7289.4071 6060.0000 10830.0000 3510.0000 8080.0000 33.11%
2019 7311.5103 6150.0000 9000.0000 5760.0000 6070.0000 9.37%
2018 6988.3506 5130.0000 11350.0000 4820.0000 5550.0000 7.98%
2017 8802.5478 10400.0000 10880.0000 4580.0000 5140.0000 -50.86%
2016 12017.4532 12220.0000 16290.0000 8210.0000 10460.0000 -18.79%
2015 14329.1429 13790.0000 19790.0000 11050.0000 12880.0000 -3.38%
2014 13487.5534 12379.9000 19200.0000 8030.0000 13330.0000 12.97%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.003B $0.000B
RedHill Biopharma Ltd. is a specialty biopharmaceutical company, focused on gastrointestinal and infectious diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment is based in Raleigh, NC, and covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded in 2009 and is headquartered in Tel Aviv, Israel.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $70.766B 23.37
Takeda Pharmaceutical (TAK) Japan $60.592B 11.26
UCB SA (UCBJY) Belgium $45.206B 0.00
BeOne Medicines - (ONC) Switzerland $38.518B 61.77
Otsuka Holdings, - (OTSKY) Japan $37.978B 14.20
Sandoz Group AG (SDZNY) Switzerland $36.696B 0.00
Daiichi Sankyo, - (DSNKY) Japan $35.209B 21.98
Zoetis (ZTS) United States $29.504B 10.85
Astellas Pharma (ALPMY) Japan $27.471B 9.09
United Therapeutics (UTHR) United States $21.215B 17.70
Merck (MKKGY) Germany $19.225B 15.34
Shionogi (SGIOY) Japan $15.862B 9.32
IPSEN (IPSEY) France $15.003B 0.00
Neurocrine Biosciences (NBIX) United States $14.864B 20.20
Summit Therapeutics (SMMT) United States $14.240B 0.00
Orion OYJ (ORINY) Finland $13.312B 19.41
Madrigal Pharmaceuticals (MDGL) United States $12.280B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Corcept Therapeutics (CORT) United States $11.922B 262.60
Eisai (ESAIY) $9.158B 0.00
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Ionis Pharmaceuticals (IONS) United States $7.385B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.572B 32.88
Oruka Therapeutics (ORKA) United States $6.287B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.975B 21.76
Definium Therapeutics (DFTX) United States $5.215B 0.00
Grifols, S.A (GRFS) Spain $4.975B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.129B 0.00
Indivior Pharmaceuticals (INDV) United States $4.117B 9.56
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Enliven Therapeutics (ELVN) United States $3.623B 0.00
Amylyx Pharmaceuticals (AMLX) United States $3.611B 0.00
Dyne Therapeutics (DYN) United States $3.195B 0.00
Hypermarcas (HYPMY) Brazil $3.172B 9.01
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.688B 0.00
Nektar Therapeutics (NKTR) United States $2.291B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.249B 16.57
Guardian Pharmacy Services (GRDN) United States $2.240B 42.44
BioCryst Pharmaceuticals (BCRX) United States $2.218B 5.99
Ocular Therapeutix (OCUL) United States $2.194B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Xencor (XNCR) United States $1.838B 0.00
KARDIGAN INC (KARD) United States $1.556B 0.00
Xeris Biopharma Holdings (XERS) United States $1.495B 117.14
Harrow (HROW) United States $1.240B 0.00
Cronos Group (CRON) Canada $1.235B 30.45
Apnimed (APMD) $1.207B 0.00
Aktis Oncology (AKTS) United States $1.176B 0.00
Seaport Therapeutics (SPTX) United States $1.145B 0.00
Savara (SVRA) United States $1.103B 0.00
Bioventus (BVS) United States $1.086B 16.99
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.974B 0.00
Avalo Therapeutics (AVTX) United States $0.889B 0.00
Theravance Biopharma (TBPH) United States $0.884B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.863B 11.90
Ardelyx (ARDX) United States $0.852B 0.00
4D Molecular Therapeutics (FDMT) United States $0.841B 0.00
Achieve Life Sciences (ACHV) Canada $0.821B 0.00
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.769B 0.00
Collegium Pharmaceutical (COLL) United States $0.741B 3.26
Silence Therapeutics (SLN) United Kingdom $0.735B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.720B 5.59
Zevra Therapeutics (ZVRA) United States $0.689B 7.35
OmniAb (OABI) United States $0.647B 0.00
Altimmune (ALT) United States $0.632B 0.00
Aquestive Therapeutics (AQST) United States $0.579B 0.00
ProKidney (PROK) United States $0.577B 0.00
Evotec AG (EVO) Germany $0.569B 0.00
Indaptus Therapeutics (INDP) United States $0.473B 0.00
Relmada Therapeutics (RLMD) United States $0.439B 0.00
ARS Pharmaceuticals (SPRY) United States $0.409B 0.00
Larimar Therapeutics (LRMR) United States $0.394B 0.00
Prelude Therapeutics (PRLD) United States $0.389B 0.00
Lexeo Therapeutics (LXEO) United States $0.345B 0.00
Avita Medical (RCEL) United States $0.339B 0.00
Century Therapeutics (IPSC) United States $0.337B 0.00
Inhibikase Therapeutics (IKT) United States $0.321B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
Lyell Immunopharma (LYEL) United States $0.270B 0.00
Elite Pharmaceuticals (ELTP) United States $0.267B 12.38
USANA Health Sciences (USNA) United States $0.261B 14.28
Galectin Therapeutics (GALT) United States $0.256B 0.00
Akebia Therapeutics (AKBA) United States $0.254B 0.00
Nature's Sunshine Products (NATR) United States $0.229B 11.13
Siga Technologies (SIGA) United States $0.226B 0.00
AleAnna (ANNA) United States $0.218B 17.21
Cardiol Therapeutics (CRDL) Canada $0.218B 0.00
Profound Medical (PROF) Canada $0.214B 0.00
Protara Therapeutics (TARA) United States $0.210B 0.00
Journey Medical (DERM) United States $0.206B 0.00
Surrozen (SRZN) United States $0.192B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.186B 0.00
Organogenesis (ORGO) United States $0.183B 0.00
Minerva Neurosciences (NERV) United States $0.175B 0.00
MediWound (MDWD) Israel $0.172B 0.00
Atrium Therapeutics (RNA) United States $0.153B 0.00
Korro Bio (KRRO) United States $0.148B 0.00
NRx Pharmaceuticals (NRXP) United States $0.144B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.140B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.134B 0.00
VAXART, INC (VXRT) United States $0.118B 3.04
Assertio Holdings (ASRT) United States $0.116B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.110B 0.00
Vivani Medical (VANI) United States $0.107B 0.00
Rafael Holdings (RFL) United States $0.107B 0.00
ElectroCore (ECOR) United States $0.105B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
PolyPid (PYPD) Israel $0.099B 0.00
Nutriband (NTRB) United States $0.099B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
HST Global (HSTC) United States $0.092B 0.00
Telomir Pharmaceuticals (TELO) United States $0.085B 0.00
Aldeyra Therapeutics (ALDX) United States $0.082B 0.00
PMV Pharmaceuticals (PMVP) United States $0.080B 0.00
Acrivon Therapeutics (ACRV) United States $0.079B 0.00
Gain Therapeutics (GANX) United States $0.077B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.076B 0.00
Champions Oncology (CSBR) United States $0.074B 0.00
Nuo Therapeutics (AURX) $0.063B 0.00
Talphera (TLPH) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.059B 0.00
Heron Therapeutics (HRTX) United States $0.059B 0.00
Veraxa Biotech AG (VRXA) United States $0.046B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.044B 0.00
Karyopharm Therapeutics (KPTI) United States $0.043B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.038B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Context Therapeutics (CNTX) United States $0.034B 0.00
Cosmos Health (COSM) United States $0.032B 0.00
Optimi Health (OPTH) Canada $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.028B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.024B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Tempest Therapeutics (TPST) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Enlivex (ENLV) Israel $0.014B 0.00
BioVie (BIVI) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00